Lactobacillus and Reduced Fasting Blood Glucose Levels

Doses used in studies

CFU/day: 10 billion (median 10 billion, IQR 10 billion–10 billion) — 1 study

Time to effect

Median: 3.7 months · IQR 3.7 months–3.7 months · Range 3.7 months–3.7 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Adverse events were similarly distributed among groups, indicating comparable safety profiles.
from: Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabet

1 of 1 paper

Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial.

2024-09-16
RCT · n = 490
Frontiers in endocrinology 15
- Xuchao Peng
- Hong Xian
- Ning Ge
- Lisha Hou
- Tianjiao Tang
- Dongmei Xie
- Langli Gao
- Jirong Yue

PubMed: 39351535
DOI: 10.3389/fendo.2024.1440286

4 Insights on

Reduced Fasting Blood Glucose Levels

High evidence
Large Human Trial
Clinical

FBG [-0.97 (-1.49 to 0.46)] post-intervention, similar to the placebo group with reductions ... but these changes were not statistically significant in PP and ITT analyses (P>0.05).

Effect: Neutral
Effect size: Small
Significant: No
Dose: 25 ml of a probiotic beverage containing over 10^8 CFU/mL, four times daily